207 related articles for article (PubMed ID: 20017941)
21. Molecular sub-classification of renal epithelial tumors using meta-analysis of gene expression microarrays.
Sanford T; Chung PH; Reinish A; Valera V; Srinivasan R; Linehan WM; Bratslavsky G
PLoS One; 2011; 6(7):e21260. PubMed ID: 21818257
[TBL] [Abstract][Full Text] [Related]
22. Use of gene expression profiles to stage concurrent endometrioid tumors of the endometrium and ovary.
Guirguis A; Elishaev E; Oh SH; Tseng GC; Zorn K; DeLoia JA
Gynecol Oncol; 2008 Feb; 108(2):370-6. PubMed ID: 18083218
[TBL] [Abstract][Full Text] [Related]
23. Population-based molecular prognosis of breast cancer by transcriptional profiling.
Ma Y; Qian Y; Wei L; Abraham J; Shi X; Castranova V; Harner EJ; Flynn DC; Guo L
Clin Cancer Res; 2007 Apr; 13(7):2014-22. PubMed ID: 17404081
[TBL] [Abstract][Full Text] [Related]
24. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.
Glinsky GV; Berezovska O; Glinskii AB
J Clin Invest; 2005 Jun; 115(6):1503-21. PubMed ID: 15931389
[TBL] [Abstract][Full Text] [Related]
25. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
Kao J; Salari K; Bocanegra M; Choi YL; Girard L; Gandhi J; Kwei KA; Hernandez-Boussard T; Wang P; Gazdar AF; Minna JD; Pollack JR
PLoS One; 2009 Jul; 4(7):e6146. PubMed ID: 19582160
[TBL] [Abstract][Full Text] [Related]
26. Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes.
Amatschek S; Koenig U; Auer H; Steinlein P; Pacher M; Gruenfelder A; Dekan G; Vogl S; Kubista E; Heider KH; Stratowa C; Schreiber M; Sommergruber W
Cancer Res; 2004 Feb; 64(3):844-56. PubMed ID: 14871811
[TBL] [Abstract][Full Text] [Related]
27. Conservation of immune gene signatures in solid tumors and prognostic implications.
Chifman J; Pullikuth A; Chou JW; Bedognetti D; Miller LD
BMC Cancer; 2016 Nov; 16(1):911. PubMed ID: 27871313
[TBL] [Abstract][Full Text] [Related]
28. A compact VEGF signature associated with distant metastases and poor outcomes.
Hu Z; Fan C; Livasy C; He X; Oh DS; Ewend MG; Carey LA; Subramanian S; West R; Ikpatt F; Olopade OI; van de Rijn M; Perou CM
BMC Med; 2009 Mar; 7():9. PubMed ID: 19291283
[TBL] [Abstract][Full Text] [Related]
29. Expression and prognostic significance of a comprehensive epithelial-mesenchymal transition gene set in renal cell carcinoma.
Chen D; Gassenmaier M; Maruschke M; Riesenberg R; Pohla H; Stief CG; Zimmermann W; Buchner A
J Urol; 2014 Feb; 191(2):479-86. PubMed ID: 24012533
[TBL] [Abstract][Full Text] [Related]
30. Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers.
Blumenthal RD; Leon E; Hansen HJ; Goldenberg DM
BMC Cancer; 2007 Jan; 7():2. PubMed ID: 17201906
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers.
Au NH; Cheang M; Huntsman DG; Yorida E; Coldman A; Elliott WM; Bebb G; Flint J; English J; Gilks CB; Grimes HL
J Pathol; 2004 Sep; 204(1):101-9. PubMed ID: 15307143
[TBL] [Abstract][Full Text] [Related]
32. A distinctive ovarian cancer molecular subgroup characterized by poor prognosis and somatic focal copy number amplifications at chromosome 19.
Sung CO; Song IH; Sohn I
Gynecol Oncol; 2014 Feb; 132(2):343-50. PubMed ID: 24321399
[TBL] [Abstract][Full Text] [Related]
33. miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations.
Teng Y; Su X; Zhang X; Zhang Y; Li C; Niu W; Liu C; Qu K
Oncotarget; 2016 Dec; 7(49):81621-81633. PubMed ID: 27835595
[TBL] [Abstract][Full Text] [Related]
34. Expression profiling of non-small cell lung carcinoma identifies metastatic genotypes based on lymph node tumor burden.
Hoang CD; D'Cunha J; Tawfic SH; Gruessner AC; Kratzke RA; Maddaus MA
J Thorac Cardiovasc Surg; 2004 May; 127(5):1332-41; discussion 1342. PubMed ID: 15115990
[TBL] [Abstract][Full Text] [Related]
35. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.
Zorn KK; Bonome T; Gangi L; Chandramouli GV; Awtrey CS; Gardner GJ; Barrett JC; Boyd J; Birrer MJ
Clin Cancer Res; 2005 Sep; 11(18):6422-30. PubMed ID: 16166416
[TBL] [Abstract][Full Text] [Related]
36. Gene expression profiles as prognostic markers in women with ovarian cancer.
Jochumsen KM; Tan Q; Høgdall EV; Høgdall C; Kjaer SK; Blaakaer J; Kruse TA; Mogensen O
Int J Gynecol Cancer; 2009 Oct; 19(7):1205-13. PubMed ID: 19823056
[TBL] [Abstract][Full Text] [Related]
37. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD
Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038
[TBL] [Abstract][Full Text] [Related]
38. Gene Set-Based Integrative Analysis Revealing Two Distinct Functional Regulation Patterns in Four Common Subtypes of Epithelial Ovarian Cancer.
Chang CM; Chuang CM; Wang ML; Yang YP; Chuang JH; Yang MJ; Yen MS; Chiou SH; Chang CC
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27527159
[TBL] [Abstract][Full Text] [Related]
39. CSIOVDB: a microarray gene expression database of epithelial ovarian cancer subtype.
Tan TZ; Yang H; Ye J; Low J; Choolani M; Tan DS; Thiery JP; Huang RY
Oncotarget; 2015 Dec; 6(41):43843-52. PubMed ID: 26549805
[TBL] [Abstract][Full Text] [Related]
40. Distinguishing key biological pathways between primary breast cancers and their lymph node metastases by gene function-based clustering analysis.
Lähdesmäki H; Hao X; Sun B; Hu L; Yli-Harja O; Shmulevich I; Zhang W
Int J Oncol; 2004 Jun; 24(6):1589-96. PubMed ID: 15138604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
